Cargando…

Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis

The present study aimed to investigate the mechanism of hepatoprotective effect of Erzhi Pill (EZP) on the liver injury via observing TSC/mTOR signaling pathway activation. The experimental liver injury was induced by 2-acetylaminofluorene (2-AAF) treatment combined with partial hepatectomy (PH). EZ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bu-gao, Zhao, Hai-mei, Lu, Xiu-yun, Wang, Xin, Zou, Yong, Xu, Rong, Yue, Hai-yang, Liu, Yi, Zuo, Zheng-yun, Liu, Duan-yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468563/ https://www.ncbi.nlm.nih.gov/pubmed/28638431 http://dx.doi.org/10.1155/2017/5653643

Ejemplares similares

Erzhi Pill(®) Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway
por: Zhao, Hai-Mei, et al.
Publicado: (2018)

Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
por: Zhou, Bu-Gao, et al.
Publicado: (2018)

The TSC-mTOR pathway regulates macrophage polarization
por: Byles, Vanessa, et al.
Publicado: (2013)

Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments
por: Zhong, Zhiguo, et al.
Publicado: (2021)

Sirt1/Foxo Axis Plays a Crucial Role in the Mechanisms of Therapeutic Effects of Erzhi Pill in Ovariectomized Rats
por: Liang, Wenna, et al.
Publicado: (2018)

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
por: Presneau, N, et al.
Publicado: (2009)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer
por: Mrozek, Evelyn M., et al.
Publicado: (2021)

Systematic Elucidation of the Potential Mechanism of Erzhi Pill against Drug-Induced Liver Injury via Network Pharmacology Approach
por: Huang, Shao-jie, et al.
Publicado: (2020)

Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?
por: Habib, Samy L, et al.
Publicado: (2016)

Hyperbaric oxygen relieves neuropathic pain through AKT/TSC2/mTOR pathway activity to induce autophagy
por: Liu, Yong-Da, et al.
Publicado: (2019)

Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated
por: Cabrera-López, Cristina, et al.
Publicado: (2015)

Methylation of Hypothalamic Tsc1-mTOR Signaling in Regulation of Obesity and Obesity Resistance
por: Wang, Yanli, et al.
Publicado: (2020)

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor
por: Dhamne, Sameer C., et al.
Publicado: (2023)

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2019)

A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shaojie, et al.
Publicado: (2020)

Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
por: Dere, Ruhee, et al.
Publicado: (2010)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats
por: Li, Xiaoya, et al.
Publicado: (2020)

Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia
por: Olney, Nicholas T., et al.
Publicado: (2017)

Effect of Sishen Pill on Memory T Cells From Experimental Colitis Induced by Dextran Sulfate Sodium
por: Ge, Wei, et al.
Publicado: (2020)

miR-301a Suppression within Fibroblasts Limits the Progression of Fibrosis through the TSC1/mTOR Pathway
por: Wang, Jiexuan, et al.
Publicado: (2020)

TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
por: Chen, Chong, et al.
Publicado: (2008)

The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function
por: Nguyen, Lena H., et al.
Publicado: (2023)

Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC)
por: Brakemeier, Susanne, et al.
Publicado: (2017)

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
por: Jin, Shan, et al.
Publicado: (2018)

Long non-coding RNA MALAT1 enhances the apoptosis of cardiomyocytes through autophagy inhibition by regulating TSC2-mTOR signaling
por: Hu, Hao, et al.
Publicado: (2019)

Sishen Pill Maintained Colonic Mucosal Barrier Integrity to Treat Ulcerative Colitis via Rho/ROCK Signaling Pathway
por: Zhang, Xiao-Yun, et al.
Publicado: (2021)

GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms
por: Salles, Daniela C, et al.
Publicado: (2022)

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling
por: Xie, Ya-Jun, et al.
Publicado: (2018)

Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma
por: Maász, Anita, et al.
Publicado: (2023)

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1–)(40) injection in ovariectomized Alzheimer’s disease model rats
por: Xie, Yongyan, et al.
Publicado: (2021)

Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma()
por: Cho, Jinhyun, et al.
Publicado: (2016)

Systematic Profiling of the Multicomponents and Authentication of Erzhi Pill by UHPLC/Q-Orbitrap-MS Oriented Rapid Polarity-Switching Data-Dependent Acquisition and Selective Monitoring of the Chemical Markers Deduced from Fingerprint Analysis
por: Jia, Li, et al.
Publicado: (2018)

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma
por: Chakraborty, Sanjukta, et al.
Publicado: (2008)

Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways
por: Gan, Boyi, et al.
Publicado: (2006)

Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma
por: Jham, Bruno C., et al.
Publicado: (2011)

Electroacupuncture Upregulated Ghrelin in Rats with Functional Dyspepsia via AMPK/TSC2/Rheb-Mediated mTOR Inhibition
por: Tang, Lei, et al.
Publicado: (2019)

mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus
por: Petrasek, Tomas, et al.
Publicado: (2021)

Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway
por: Wang, Wenjuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nom94o39322lubonfqavq6dr8t